Viz.ai Ads
viz.ai
Viz.ai is currently running 276 ads across LinkedIn — 276 on LinkedIn. Browse Viz.ai's live ad creative, messaging, and the platforms they advertise on below — updated automatically by ForesightIQ.
Ads are just the surface. See Viz.ai's full go-to-market & positioning strategy in a free competitive intel briefing.
Showing 24 of 276 ads · up to 24 per platform
What health system leaders said about scaling AI
Not a vendor panel. Not a keynote about what's possible. In January, we brought together CMOs, CIOs, and clinical leade…
The constraint isn't the AI. It's execution.
You've already made the investment in AI. The pilots worked. The clinicians saw the value. Leadership signed off. Now …
Forbes just covered the AI-ECG space, and Viz.ai's role in it. The ECG has been a clinical workhorse for over a century…
Forbes just covered the AI-ECG space, and Viz.ai's role in it. The ECG has been a clinical workhorse for over a century…
Forbes just covered the AI-ECG space, and Viz.ai's role in it. The ECG has been a clinical workhorse for over a century…
How did Viz.ai become the #1 clinical decision support tool in the country (ahead of EHRs and other vendors)? Context: …
27% would have been missed. AI found them
27% of patients flagged by Viz Aneurysm® would not have received appropriate specialist follow-up without AI. They were…
27% would have been missed. AI found them
27% of patients flagged by Viz Aneurysm® would not have received appropriate specialist follow-up without AI. They were…
Forbes just covered the AI-ECG space, and Viz.ai's role in it. The ECG has been a clinical workhorse for over a century…
Governance isn't a speed bump. It's a competitive tool.
Your governance process was built to protect the organization. But when it takes 8 to 14 months to approve a promising …
How Health Systems Are Scaling Coordinated Care
AI is increasingly used to identify patients and support next steps in care. The focus now is making that follow-throug…
By the time it's approved, you're already behind.
You know this feeling. A promising AI initiative clears clinical review. Then it sits in the queue. Then it needs anoth…
Forbes just covered the AI-ECG space, and Viz.ai's role in it. The ECG has been a clinical workhorse for over a century…
How Health Systems Are Scaling Coordinated Care
AI is increasingly used to identify patients and support next steps in care. The focus now is making that follow-throug…
Each week I hear from health system C-suites about their AI hopes and headaches. A tension I keep hearing: build intern…
Forbes just covered the AI-ECG space, and Viz.ai's role in it. The ECG has been a clinical workhorse for over a century…
By the time it's approved, you're already behind.
You know this feeling. A promising AI initiative clears clinical review. Then it sits in the queue. Then it needs anoth…
Governance isn't a speed bump. It's a competitive tool.
Your governance process was built to protect the organization. But when it takes 8 to 14 months to approve a promising …
Viz.ai Launches Viz Pulmonary Suite
Today we announced the Viz Pulmonary Suite 🫁 the first comprehensive AI-powered solution dedicated to pulmonary care de…
Grateful to Andy Kessler for telling the Viz.ai story in The Wall Street Journal. In an agentic world, value accrues to …
By the time it's approved, you're already behind.
You know this feeling. A promising AI initiative clears clinical review. Then it sits in the queue. Then it needs anoth…
Viz.ai is ranked #1 again. For the second consecutive year, Viz.ai earned the top spot in the Black Book survey of AI C…
Transform Healthcare with Scalable AI
Healthcare doesn’t have an AI problem. The challenge now is execution. We don’t need better models. We need systems t…
The The Wall Street Journal articles covers much of it - but in short, the next wave of AI isn’t simple summarizations o…
See Viz.ai's full go-to-market & positioning strategy
These ads are just the surface. In a 30-minute competitive intel briefing we walk you through Viz.ai's messaging, channels, pricing moves, and the signals behind what they'll do next — so your team sees it coming first.
30 minutes · free · tailored to Viz.ai
Frequently asked questions about Viz.ai's ads
What advertising is Viz.ai currently running?
Viz.ai is actively running advertising campaigns exclusively on LinkedIn. These ads focus on thought leadership, scaling AI in healthcare, new product launches, and the company's market leadership in clinical decision support tools.
Where does Viz.ai advertise its solutions?
Viz.ai primarily advertises on LinkedIn, utilizing its platform to reach healthcare leaders and professionals. Their campaigns showcase insights into AI execution, governance, and the impact of Viz.ai's products on patient care.
Does Viz.ai use Google Ads or Facebook Ads?
Based on current observations, Viz.ai does not appear to be running any active advertising campaigns on Google Ads or Facebook/Meta platforms. Their advertising efforts are concentrated solely on LinkedIn.
Roughly how many ads is Viz.ai running on LinkedIn?
Viz.ai is running a significant number of ads on LinkedIn, with approximately 276 different ad creatives detected. This volume suggests a robust and varied advertising strategy targeting healthcare professionals on the platform.
What are some examples of Viz.ai ad creative?
Viz.ai's ad creative includes headlines like 'What health system leaders said about scaling AI' and '27% would have been missed. AI found them.' They also feature content from Forbes, The Wall Street Journal, and Black Book rankings.
What messaging and themes does Viz.ai use in its advertising?
Viz.ai's advertising messaging centers on the execution and scaling of AI in healthcare, overcoming challenges like governance, and highlighting patient outcomes. Key themes include thought leadership, product innovation like Viz Pulmonary Suite, and market leadership in clinical decision support.
What does Viz.ai advertise in its ad campaigns?
Viz.ai advertises its AI-powered solutions for healthcare, emphasizing their role in patient identification, coordinated care, and clinical decision support. The ads frequently reference specific products like Viz Aneurysm and the newly launched Viz Pulmonary Suite.
What offers or calls-to-action (CTAs) are in Viz.ai ads?
Viz.ai's ads often promote thought leadership content, such as insights from health system leaders, articles from publications like Forbes and The Wall Street Journal, and discussions on scaling AI. Their messaging aims to engage professionals with valuable industry perspectives rather than direct sales offers.
What does Viz.ai's advertising strategy suggest about its go-to-market approach?
Viz.ai's focused advertising on LinkedIn suggests a go-to-market strategy targeting healthcare C-suites, clinical leaders, and industry professionals. The emphasis on thought leadership, executive quotes, and product innovation aims to establish credibility and influence decision-makers in the healthcare sector.
Powered by ForesightIQ · Competitor ads from Google, Meta & LinkedIn